Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 33, 2021 - Issue 7
395
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A qualitative study of antiretroviral therapy adherence interruptions among young Latino men who have sex with men with HIV: Project D.A.I.L.Y.

, , ORCID Icon, , , , ORCID Icon, & show all
Pages 962-969 | Received 29 Aug 2020, Accepted 04 Jan 2021, Published online: 23 Jan 2021

References

  • Ajzen, I. (1991). The theory of planned behaviour. Organizational Behavior and Human Decision Processes, 50(2), 179–211. https://doi.org/10.1080/08870446.2011.613995
  • Anderson, K., Biello, K., Rosenberger, J. G., Novak, D., Mayer, K., Carey, K., & Mimiaga, M. J. (2018). The impact of social support and partner relationship dynamics on engagement in HIV care and antiretroviral treatment adherence among MSM in Latin America. AIDS Care, 30(11), 1406–1412. https://doi.org/10.1080/09540121.2018.1456641
  • Bae, S., Chung, T., Ferreira, D., Dey, A. K., & Suffoletto, B. (2018). Mobile phone sensors and supervised machine learning to identify alcohol use events in young adults: Implications for just-in-time adaptive interventions. Addictive Behaviors, 83, 42–47. https://doi.org/10.1016/j.addbeh.2017.11.039
  • Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43(7), 939–941. https://doi.org/10.1086/507526
  • Boyatzis, R. E. (1998). Transforming qualitative information: Thematic analysis and code development (1st ed.). SAGE Publications Inc.
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
  • Bronfenbrenner, U. (1989). Ecological systems theory. In R. Vasta (Ed.), Annals of child development (Vol. 6, pp. 187–249). Jessica Kingsley Publishers.
  • Clarridge, K. E., Blazkova, J., Einkauf, K., Petrone, M., Refsland, E. W., Justement, J. S., Shi, V., Huiting, E. D., Seamon, C. A., Lee, G. Q., Yu, X. G., Moir, S., Sneller, M. C., Lichterfeld, M., & Chun, T.-W. (2018). Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals. PLOS Pathogens, 14(1), e1006792.
  • Cohen, C. J., Colson, A. E., Sheble-Hall, A. G., McLaughlin, K. A., & Morse, G. D. (2007). Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV Clinical Trials, 8(1), 19–23. https://doi.org/10.1310/hct0801-19
  • Cook, P. F., McElwain, C. J., & Bradley-Springer, L. A. (2010). Feasibility of a daily electronic survey to study prevention behavior with HIV-infected individuals. Research in Nursing & Health, 33(3), 221–234. https://doi.org/10.1002/nur.20381
  • Cook, P. F., McElwain, C. J., & Bradley-Springer, L. A. (2016). Brief report on ecological momentary assessment: Everyday states predict HIV prevention behaviors. BMC Research Notes, 9, 9. https://doi.org/10.1186/s13104-015-1814-4
  • Cook, P. F., Schmiege, S. J., Bradley-Springer, L., Starr, W., & Carrington, J. M. (2018). Motivation as a Mechanism for daily experiences’ effects on HIV medication adherence. The Journal of the Association of Nurses in AIDS Care: JANAC, 29(3), 383–393. https://doi.org/10.1016/j.jana.2017.09.003
  • Curioso, W. H., Kepka, D., Cabello, R., Segura, P., & Kurth, A. E. (2010). Understanding the facilitators and barriers of antiretroviral adherence in Peru: A qualitative study. BMC Public Health, 10, 13. https://doi.org/10.1186/1471-2458-10-13
  • Dowshen, N., Kuhns, L. M., Gray, C., Lee, S., & Garofalo, R. (2013). Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS and Behavior, 17(6), 2237–2243. https://doi.org/10.1007/s10461-013-0464-6
  • Dvorak, R. D., Pearson, M. R., & Day, A. M. (2014). Ecological momentary assessment of acute alcohol use disorder symptoms: Associations with mood, motives, and use on planned drinking days. Experimental and Clinical Psychopharmacology, 22(4), 285–297. https://doi.org/10.1037/a0037157
  • Fisher, J. D., & Fisher, W. A. (1992). Changing AIDS-risk behavior. Psychological Bulletin, 111(3), 455–474. https://doi.org/10.1037/0033-2909.111.3.455
  • Ford, N., Darder, M., Spelman, T., Maclean, E., Mills, E., & Boulle, A. (2010). Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: Five-year follow up of an observational cohort. PLOS ONE, 5(5), e10460. https://doi.org/10.1371/journal.pone.0010460
  • Ford, N., Migone, C., Calmy, A., Kerschberger, B., Kanters, S., Nsanzimana, S., Mills, E. J., Meintjes, G., Vitoria, M., Doherty, M., & Shubber, Z. (2018). Benefits and risks of rapid initiation of antiretroviral therapy. AIDS (London, England), 32(1), 17–23. https://doi.org/10.1097/QAD.0000000000001671
  • Gant, Z., Dailey, A., Hu, X., & Johnson, A. S. (2017). HIV care outcomes among Hispanics or Latinos with diagnosed HIV infection—United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 66(40), 1065–1072.
  • Genberg, B. L., Wilson, I. B., Bangsberg, D. R., Arnsten, J., Goggin, K., Remien, R. H., Simoni, J., Gross, R., Reynolds, N., Rosen, M., & Liu, H. (2012). Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. Aids (London, England), 26(11), 1415–1423. https://doi.org/10.1097/QAD.0b013e328354bed6
  • Günthard, H. F., Saag, M. S., Benson, C. A., del Rio, C., Eron, J. J., Gallant, J. E., Hoy, J. F., Mugavero, M. J., Sax, P. E., Thompson, M. A., Gandhi, R. T., Landovitz, R. J., Smith, D. M., Jacobsen, D. M., & Volberding, P. A. (2016). Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society-USA Panel. JAMA, 316(2), 191–210. https://doi.org/10.1001/jama.2016.8900
  • Haberer, J. E., Musinguzi, N., Boum, Y., Siedner, M. J., Mocello, A. R., Hunt, P. W., Martin, J. N., & Bangsberg, D. R. (2015). Duration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural Uganda. Journal of Acquired Immune Deficiency Syndromes (1999), 70(4), 386–392. https://doi.org/10.1097/QAI.0000000000000737
  • Harkness, A., Bainter, S. A., O’Cleirigh, C., Mendez, N. A., Mayer, K. H., & Safren, S. A. (2018). Longitudinal effects of syndemics on ART non-adherence among sexual minority men. AIDS and Behavior, 22(8), 2564–2574. https://doi.org/10.1007/s10461-018-2180-8
  • Harris, N. S., Johnson, A. S., Huang, Y.-L. A., Kern, D., Fulton, P., Smith, D. K., Valleroy, L. A., & Hall, H. I. (2019). Vital signs: Status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis—United States, 2013–2018. MMWR Morbidity and Mortality Weekly Report, 68(48), 1117–1123.
  • Hightow-Weidman, L., Muessig, K., Claude, K., Roberts, J., Zlotorzynska, M., & Sanchez, T. (2020). Maximizing digital interventions for youth in the midst of Covid-19: Lessons from the adolescent trials network for HIV interventions. AIDS and Behavior, 1–5. https://doi.org/10.1007/s10461-020-02870-w
  • Janda, L. H., Markowski, E., Derlega, V. J., Nezlek, J., & McCain, N. (2006). Daily events and mood state among individuals living with HIV: Examination of the within-persons approach to data collection using daily diary methodology. Journal of Nursing Measurement, 14(2), 116–128. https://doi.org/10.1891/jnm-v14i2a004
  • Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers, M. A. G., & Nieuwkerk, P. T. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12, 142. https://doi.org/10.1186/PREACCEPT-1453408941291432
  • Li, Z., Purcell, D. W., Sansom, S. L., Hayes, D., & Hall, H. I. (2019). Vital signs: HIV transmission along the continuum of care — United States, 2016. MMWR Morbidity and Mortality Weekly Report, 68(11), 267–272. https://doi.org/10.15585/MMWR.MM6811E1
  • Maggiolo, F., Ravasio, L., Ripamonti, D., Gregis, G., Quinzan, G., Arici, C., Airoldi, M., & Suter, F. (2005). Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clinical Infectious Diseases, 40(1), 158–163. https://doi.org/10.1086/426595
  • Maughan-Brown, B., Harrison, A., Galárraga, O., Kuo, C., Smith, P., Bekker, L.-G., & Lurie, M. N. (2019). Factors affecting linkage to HIV care and ART initiation following referral for ART by a mobile health clinic in South Africa: Evidence from a multimethod study. Journal of Behavioral Medicine, 42(5), 883–897. https://doi.org/10.1007/s10865-018-0005-x
  • Mi, T., Li, X., Zhou, G., Qiao, S., Shen, Z., & Zhou, Y. (2020). HIV disclosure to family members and medication adherence: Role of social support and self-efficacy. AIDS and Behavior, 24(1), 45–54. https://doi.org/10.1007/s10461-019-02456-1
  • Miron, R. E., & Smith, R. J. (2010). Modelling imperfect adherence to HIV induction therapy. BMC Infectious Diseases, 10, 6. https://doi.org/10.1186/1471-2334-10-6
  • Murphy, D. A., Roberts, K. J., Hoffman, D., Molina, A., & Lu, M. C. (2003). Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care, 15(2), 217–230. https://doi.org/10.1080/0954012031000068362
  • Parienti, J.-J., Das-Douglas, M., Massari, V., Guzman, D., Deeks, S. G., Verdon, R., & Bangsberg, D. R. (2008). Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PloS One, 3(7), e2783. https://doi.org/10.1371/journal.pone.0002783
  • Park, L. S., Tate, J. P., Sigel, K., Brown, S. T., Crothers, K., Gibert, C., Goetz, M. B., Rimland, D., Rodriguez-Barradas, M. C., Bedimo, R. J., Justice, A. C., & Dubrow, R. (2018). Association of viral suppression with lower AIDS-defining and non-AIDS-defining cancer incidence in HIV-infected veterans: A prospective cohort study. Annals of Internal Medicine, 169(2), 87–96. https://doi.org/10.7326/M16-2094
  • Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30. https://doi.org/10.7326/0003-4819-133-1-200007040-00004
  • QSR International. (1999). NVivo Qualitative Data Analysis Software.
  • Reis, H. T. (2012). Why researchers should think “real-world”: A conceptual rationale. In M. R. Mehl & T. S. Conner (Eds.), Handbook of research methods for studying daily life (pp. 3–21). Guilford.
  • Rodger, A. J., Lodwick, R., Schechter, M., Deeks, S., Amin, J., Gilson, R., Paredes, R., Bakowska, E., Engsig, F. N., Phillips, A., & Insight Smart, E. S. G. (2013). Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS (London, England), 27(6), 973–979. https://doi.org/10.1097/QAD.0b013e32835cae9c
  • Rudy, B. J., Sleasman, J., Kapogiannis, B., Wilson, C. M., Bethel, J., Serchuck, L., Ahmad, S., & Cunningham, C. K. (2009). Short-cycle therapy in adolescents after continuous therapy with established viral suppression: The impact on viral load suppression. AIDS Research and Human Retroviruses, 25(6), 555–561. https://doi.org/10.1089/aid.2008.0203
  • Ryan, G. W., & Wagner, G. J. (2003). Pill taking “routinization”: A critical factor to understanding episodic medication adherence. AIDS Care, 15(6), 795–806. https://doi.org/10.1080/09540120310001618649
  • Sauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2018). An update on the barriers to adherence and a definition of self-report non-adherence given advancements in antiretroviral therapy (ART). AIDS and Behavior, 22(3), 939–947. https://doi.org/10.1007/s10461-017-1759-9
  • Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37(8), 1112–1118. https://doi.org/10.1086/378301
  • Sheehan, D. M., Cosner, C., Fennie, K. P., Gebrezgi, M. T., Cyrus, E., Maddox, L. M., Levison, J. H., Spencer, E. C., Niyonsenga, T., & Trepka, M. J. (2018). Role of country of birth, testing site, and neighborhood characteristics on nonlinkage to HIV care among Latinos. AIDS Patient Care and STDs, 32(4), 165–173. https://doi.org/10.1089/apc.2018.0021
  • Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., & Ford, N. (2016). Patient-reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Medicine, 13(11), e1002183. https://doi.org/10.1371/journal.pmed.1002183
  • Shuter, J., Sarlo, J. A., Kanmaz, T. J., Rode, R. A., & Zingman, B. S. (2007). HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. Journal of Acquired Immune Deficiency Syndromes (1999), 45(1), 4–8. https://doi.org/10.1097/QAI.0b013e318050d8c2
  • Singh, S., Mitsch, A., & Wu, B. (2017). HIV care outcomes among men who have sex with men with diagnosed HIV infection — United States, 2015. MMWR Morbidity and Mortality Weekly Report, 66(37), 969–974. https://doi.org/10.15585/mmwr.mm6637a2
  • Slavish, D. C., Scaglione, N. M., Hultgren, B. A., & Turrisi, R. (2019). An ecological momentary assessment of affect, mental health symptoms, and decisions to drink among first-year college women: A pilot study. Prevention Science, 20(5), 753–764. https://doi.org/10.1007/s11121-018-0966-6
  • Smith, C. J., Sabin, C. A., Youle, M. S., Kinloch-de Loes, S., Lampe, F. C., Madge, S., Cropley, I., Johnson, M. A., & Phillips, A. N. (2004). Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. The Journal of Infectious Diseases, 190(10), 1860–1868. https://doi.org/10.1086/425075
  • Stirratt, M. J., Remien, R. H., Smith, A., Copeland, O. Q., Dolezal, C., & Krieger, D. (2006). The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS and Behavior, 10(5), 483–493. https://doi.org/10.1007/s10461-006-9106-6
  • Suffoletto, B., Kristan, J., Chung, T., Jeong, K., Fabio, A., Monti, P., & Clark, D. B. (2015). An interactive text message intervention to reduce binge drinking in young adults: A randomized controlled trial with 9-month outcomes. PloS One, 10(11), e0142877. https://doi.org/10.1371/journal.pone.0142877
  • Voisin, D. R., Quinn, K., Kim, D. H., & Schneider, J. A. (2017). Longitudinal analysis of antiretroviral adherence Among young Black Men Who have Sex With Men. The Journal of Adolescent Health, 60(4), 411–416. https://doi.org/10.1016/j.jadohealth.2016.10.428

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.